Navigation Links
InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone
Date:6/29/2010

LOS ALTOS, Calif., June 29 /PRNewswire/ -- InteKrin Therapeutics presented 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® (pioglitazone), yesterday at the American Diabetes Association annual meeting in Orlando, FL.

INT131 besylate (INT131) is a novel, non-TZD, selective oral PPAR-gamma modulator (SPPARM) designed to improve glucose metabolism while minimizing the side effects of the TZD full PPAR-gamma agonists such as Actos®: fluid retention (edema), CHF, bone fracture, and weight gain. The Phase 2b trial, INT131-007, was a 366 patient 24 wk double blind study comparing 4 doses of INT131 to maximal dose Actos® (pioglitazone) or placebo in patients with poorly controlled T2DM on stable dose sulfonylurea (SU) with or without metformin (met). Lower extremity edema was assessed with a predefined scoring tool designed for maximal sensitivity for pitting edema at baseline, 12, and 24 wks. Results show INT131 improved glycemic control as measured by HbA1c comparable to Actos® but without evidence of any significant change in edema compared to baseline or placebo. Substantial edema was noted in the pioglitazone group, consistent with published data. These findings support the SPPARM function of INT131 and suggest it represents a safer insulin sensitizer.

"This data clearly differentiates INT131 besylate from pioglitazone with respect to the important clinical parameter of edema," remarked Dr. Alex DePaoli, Acting Chief Medical Officer of InteKrin Therapeutics, who presented the data. "These findings are consistent with previous clinical data and support the advantages of the SPPARM nature of this agent."

"Insulin
'/>"/>

SOURCE InteKrin Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
2. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
3. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
4. InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
5. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
6. InteKrin Therapeutics to Present Phase 2b Clinical Data for Edema at the 2010 American Diabetes Association Annual Meeting
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 Asterias ... company in the emerging field of regenerative medicine, ... meeting with the investment community to review the ... in spinal cord injury on Friday, May 8, ... clinical trial and future planned clinical activities for ...
(Date:5/6/2015)... SAN DIEGO , May 6, 2015  Mirati ... financial results for the first quarter ended March 31, ... programs. "We continue to make progress ... M. Baum , M.D., Ph.D., president and CEO, Mirati. ... at the upcoming American Society of Clinical Oncology meeting ...
(Date:5/6/2015)... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... 31, 2015.  The net loss and the loss from ... $13.0 million, respectively, compared to $10.7 million and $8.8 ... March 31, 2015, Alexza had consolidated cash, cash equivalents, ... "We continue to focus on ways in which ...
Breaking Medicine Technology:Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 2Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 3Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 4Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 5Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10
(Date:5/6/2015)... As the exclusive hospital of the Tampa Bay ... Ship at Raymond James Stadium for all the “Bucs Babies” ... be drafted into the “Bucs Babies” program last year. ... with children, particularly those born at the Florida Hospitals here ... fans. I really enjoyed my time participating in the festivities, ...
(Date:5/6/2015)... Springs, Texas (PRWEB) May 06, 2015 ... stages of the HIMSS EMR Adoption Model, the ... paper, improve patient engagement and automate processes. The ... transitioned from paper-driven to electronic workflows, patient registration ... hard copies of consents. With HIMSS Stage 7 ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and ... they will now conduct their cooling services, including air ... to commercial and residential units. Strata complex air conditioning ... of technical knowledge as well as a professionally trained ... will take away any old air conditioning unit to ...
(Date:5/6/2015)... 06, 2015 Prime Pacific Health ... excited to announce a new series of universal, ... industry’s carbon footprint while improving treatment efficacy and ... Eco-Flex™, the world’s first waste hose designed ... for hydrotherapists,” claims the company’s president, Mr. Delmar ...
(Date:5/6/2015)... 2015 Animals make just as good friends ... good for your health. An Ohio veterinarian has ... he's seeing with health advantages of owning a pet. , ... comes to pet ownership, there are proven health benefits for ... Leffler of the Animal Medical Center of Streetsboro ...
Breaking Medicine News(10 mins):Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3
... -- Cancer patients taking the drugs sunitinib and sorafenib ... drugs don,t cause as much damage to the immune ... study included 40 volunteers in the Netherlands, including 16 ... treated with sorafenib. Seven patients with metastatic renal cell ...
... San Diego, Calif., has joined a national consortium of research ... a library of primary human tumors with the goal of ... a consortium member, STSI will provide solid human tumor samples ... scientific study. STSI scientists will then have access to the ...
... & Science University have discovered a naturally occurring disease in ... a discovery that could have a major impact on ... The disease that the researchers discovered in monkeys at OHSU,s ... virus that could give significant clues into how multiple sclerosis ...
... (HealthDay News) -- Many members of low-income families are not ... In assessing the families, eating patterns and the nutritional ... 70 percent of the 100 families, who were newly enrolled ... amounts of several vital nutrients, including vitamins A and C, ...
... dean of the University of Houston,s College of Optometry (UHCO) ... as the first UHCO-affiliated person to be inducted into the ... O.D., who was the UHCO dean from 1979 to 1990, ... Gerald E. Lowther, O.D. during the American Optometric Association ...
... a tax on soda is a no-brainer in advancing the nation,s ... recent years that conclude that sugary drinks have a lot to ... people tend to drink diet sodas, and therefore taxing soft drinks ... in combating obesity, according to a new Northwestern University study. ...
Cached Medicine News:Health News:Certain Cancer Drugs Don't Interfere With Flu Vaccine: Study 2Health News:Scripps Translational Science Institute joins Jackson Laboratory tumor consortium 2Health News:Researchers at Oregon Health & Science University discover MS-like disease in monkeys 2Health News:Low-Income Families Often Miss Out on Proper Nutrition 2Health News:Former dean first from UH to be inducted into Optometry Hall of Fame 2Health News:Can soda tax curb obesity? 2
The LCS complete knee offers grit-blast textured components for cemented implantation and POROCOAT Porous Coated patellar, femoral and tibial components for cementless fixation....
... Optetrak system includes a cruciate sparing ... flange mates with both resurfacing and ... precise, repeatable kinematics and fit with ... reduce wear. Constant cutting guide peg ...
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i...
Medicine Products: